Abstract:Objective: Accumulated studies have revealed that oxidative stress and inflammation play important roles in the development of OSA related cognitive dysfunction. Galectin-3, a member of the galectin family, has been reported to be involved in the neuroinflammatory diseases. However, the relationship between Galectin-3 and cognitive impairment in OSA remains ambiguous. Materials and methods: 47 new diagnosed OSA patients and 18 age-, gender-, education- and body mass index-matched healthy control subjects were enrolled in the present study. All subjects underwent whole-night in-laboratory polysomnography (PSG). Montreal Cognitive Assessment (MoCA) was used to evaluated the cognitive function of OSA patients. Serum Galectin-3, interleukin (IL)-1b and IL-8 were examined by enzyme-linked immunosorbent assay (ELISA). The levels of malonaldehyde (MDA), superoxide dismutase (SOD) and catalase (CAT) were measured to evaluate oxidative stress. Protein level of Galectin-3 and NLRP3 in peripheral blood mononuclear cells (PBMCs) and human microglial clone 3 (HMC3) cells were measured by Western Blot. Results: Serum Galectin-3 level in severe OSA patients (2.31 +/- 0.43 ng/m) was higher than those in mildmoderate OSA patients (1.87 +/- 0.32 ng/m, p < 0.001) and those in the healthy controls (1.56 +/- 0.22 ng/ml, p < 0.001). Similarly, Galectin-3 level in PBMCs was increased with disease severity (p < 0.01). In addition, OSA patients also showed higher levels of inflammation and oxidative stress (p < 0.01). Patients with OSA scored significantly lower than healthy controls on the MoCA test after controlling for age, gender, education, and BMI. CPAP treatment for 12 weeks effectively reduced the levels of Galectin-3, inflammation and oxidative stress, as well as improved cognitive function of severe OSA patients. Closed correlations were observed between Galectin-3 with sleep respiratory parameters and cognitive dysfunction. In addition, we explored the underlying mechanism of Galectin-3 in neuroinflammation and oxidative stress. We treated HMC3 cells with LPS to mimic neuroinflammatory response in vitro. The results showed that LPS treatment led to a dose-dependent increase in Galectin-3 expression, meanwhile induced inflammation and oxidative stress. Inhibiting Galectin-3 with a specific Galectin-3 inhibitor, TD139, significantly ameliorated LPS-induced neuroinflammation and oxidative stress via suppressing NLRP3. Conclusion: Current findings suggest that increased Galectin-3 might be involved in the cognitive impairment of OSA patients by promoting neuroinflammation and oxidative stress via regulating NLRP3. These results suggested that Galectin-3 inhibition may exert a protective role against the neurocognitive dysfunction associated with OSA.

NLRP3 Inflammasome Triggers Inflammation of Obstructive Sleep Apnea

The NLRP3 Inflammasome is Involved in Resident Intruder Paradigm-Induced Aggressive Behaviors in Mice

The relationship between inflammation and neurocognitive dysfunction in obstructive sleep apnea syndrome

NLRP3 Deficiency Protects Against Intermittent Hypoxia-Induced Neuroinflammation and Mitochondrial ROS by Promoting the PINK1-Parkin Pathway of Mitophagy in a Murine Model of Sleep Apnea

NLRP3/miR-223-3p axis attenuates neuroinflammation induced by chronic intermittent hypoxia

The Role of Inflammation in Cognitive Impairment of Obstructive Sleep Apnea Syndrome

NLRP3 Inﬂammasome Mediates Chronic Intermittent Hypoxia‐induced Renal Injury Implication of the Microrna‐155/foxo3a Signaling Pathway

Gut microbiota has important roles in the obstructive sleep apnea-induced inflammation and consequent neurocognitive impairment

Objective Short Sleep Duration is Related to the Peripheral Inflammasome Dysregulation in Patients with Chronic Insomnia

NLRP3 inflammasome regulates astrocyte transformation in brain injury induced by chronic intermittent hypoxia

Role of β-adrenergic signaling and the NLRP3 inflammasome in chronic intermittent hypoxia-induced murine lung cancer progression

Involvement of Galectin-3 in Neurocognitive Impairment in Obstructive Sleep Apnea Via Regulating Inflammation and Oxidative Stress Through NLRP3.

Blocking the LncRNA MALAT1/miR-224-5p/NLRP3 Axis Inhibits the Hippocampal Inflammatory Response in T2DM With OSA

[Lower Grade Chronic Inflammation is Associated with Obstructive Sleep Apnea Syndrome in Type 2 Diabetes Mellitus].

TDP43/HDAC6/Prdx1 Signaling Pathway Participated in the Cognitive Impairment of Obstructive Sleep Apnea Via Regulating Inflammation and Oxidative Stress

Novel Susceptibility Genes and Biomarkers for Obstructive Sleep Apnea: Insights from Genetic and Inflammatory Proteins

The NLRP3 inflammasome: contributions to inflammation-related diseases

Obstructive Sleep Apnea-Associated Intermittent Hypoxia-Induced Immune Responses in Males, Pregnancies, and Offspring

NLRP3 Inflammasome and Pulmonary Diseases

NLRP3 Inflammasome: A key contributor to the inflammation formation

NLRP3 inflammasome: a key player in the pathogenesis of life-style disorders